[{"address1": "1500 Broadway", "address2": "Suite 1401", "city": "New York", "state": "NY", "zip": "10036", "country": "United States", "phone": "332 208 6102", "website": "https://www.nuvationbio.com", "industry": "Biotechnology", "industryKey": "biotechnology", "industryDisp": "Biotechnology", "sector": "Healthcare", "sectorKey": "healthcare", "sectorDisp": "Healthcare", "longBusinessSummary": "Nuvation Bio Inc., a clinical-stage biopharmaceutical company, focuses on developing therapeutic candidates for oncology. Its lead product candidate is taletrectinib, an ROS1 inhibitor for the treatment of patients with ROS1+ non-small cell lung cancer. The company is also developing Safusidenib, an inhibitor of mutant isocitrate dehydrogenase 1 in phase 2 clinical trials; NUV-1511, a drug-drug conjugate for use in chemotherapy agent that suppresses the growth of various advanced solid tumors; and NUV-868, a binding domain 2 bromodomain and extra-terminal inhibitor that inhibits bromodomain-containing protein 4. The company was founded in 2018 and is headquartered in New York, New York.", "fullTimeEmployees": 291, "companyOfficers": [{"maxAge": 1, "name": "Dr. David T. Hung M.D.", "age": 66, "title": "Founder, President, CEO & Chairman", "yearBorn": 1958, "fiscalYear": 2024, "totalPay": 1197394, "exercisedValue": 0, "unexercisedValue": 825000}, {"maxAge": 1, "name": "Dr. Gary  Hattersley Ph.D.", "age": 57, "title": "Chief Scientific Officer", "yearBorn": 1967, "fiscalYear": 2024, "totalPay": 776760, "exercisedValue": 0, "unexercisedValue": 532020}, {"maxAge": 1, "name": "Ms. Colleen  Sjogren", "age": 53, "title": "Chief Commercial Officer", "yearBorn": 1971, "fiscalYear": 2024, "totalPay": 615841, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Philippe Pierre Sauvage", "age": 47, "title": "CFO & Principal Financial Officer", "yearBorn": 1977, "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Moses  Makunje CPA", "age": 46, "title": "VP of Finance and Principal Accounting & Financial Officer", "yearBorn": 1978, "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Stephen  Dang Ph.D.", "title": "Senior VP, General Counsel & Corporate Secretary", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Stacy  Markel", "age": 59, "title": "Chief People Officer", "yearBorn": 1965, "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. David C. Hanley Ph.D.", "age": 54, "title": "Chief Technical Operations Officer", "yearBorn": 1970, "fiscalYear": 2024, "totalPay": 586040, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Kerry A. Wentworth", "age": 51, "title": "Chief Regulatory Officer", "yearBorn": 1973, "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. David  Liu M.D., Ph.D.", "age": 54, "title": "Chief Medical Officer", "yearBorn": 1970, "fiscalYear": 2024, "totalPay": 677151, "exercisedValue": 0, "unexercisedValue": 0}], "auditRisk": 5, "boardRisk": 8, "compensationRisk": 8, "shareHolderRightsRisk": 10, "overallRisk": 10, "governanceEpochDate": 1764547200, "compensationAsOfEpochDate": 1735603200, "executiveTeam": [], "maxAge": 86400, "priceHint": 2, "previousClose": 8.99, "open": 9.02, "dayLow": 9.01, "dayHigh": 9.53, "regularMarketPreviousClose": 8.99, "regularMarketOpen": 9.02, "regularMarketDayLow": 9.01, "regularMarketDayHigh": 9.53, "payoutRatio": 0.0, "beta": 1.587, "forwardPE": -33.714283, "volume": 8224076, "regularMarketVolume": 8224076, "averageVolume": 8598193, "averageVolume10days": 6525780, "averageDailyVolume10Day": 6525780, "bid": 9.46, "ask": 9.45, "bidSize": 4500, "askSize": 3500, "marketCap": 3236347648, "fiftyTwoWeekLow": 1.54, "fiftyTwoWeekHigh": 9.53, "allTimeHigh": 15.23, "allTimeLow": 0.95, "priceToSalesTrailing12Months": 120.994, "fiftyDayAverage": 6.1132, "twoHundredDayAverage": 3.34555, "trailingAnnualDividendRate": 0.0, "trailingAnnualDividendYield": 0.0, "currency": "USD", "tradeable": false, "enterpriseValue": 2744850688, "profitMargins": 0.0, "floatShares": 231594269, "sharesOutstanding": 341833433, "sharesShort": 52605709, "sharesShortPriorMonth": 67690040, "sharesShortPreviousMonthDate": 1761868800, "dateShortInterest": 1764288000, "sharesPercentSharesOut": 0.1534, "heldPercentInsiders": 0.19048999, "heldPercentInstitutions": 0.65786004, "shortRatio": 4.65, "shortPercentOfFloat": 0.25, "impliedSharesOutstanding": 342833433, "bookValue": 0.951, "priceToBook": 9.9263935, "lastFiscalYearEnd": 1735603200, "nextFiscalYearEnd": 1767139200, "mostRecentQuarter": 1759190400, "netIncomeToCommon": -217480000, "trailingEps": -0.49, "forwardEps": -0.28, "enterpriseToRevenue": 102.619, "enterpriseToEbitda": -11.854, "52WeekChange": 2.5355806, "SandP52WeekChange": 0.14402747, "quoteType": "EQUITY", "currentPrice": 9.44, "targetHighPrice": 18.0, "targetLowPrice": 8.0, "targetMeanPrice": 11.25, "targetMedianPrice": 10.5, "recommendationMean": 1.22222, "recommendationKey": "strong_buy", "numberOfAnalystOpinions": 8, "totalCash": 549044992, "totalCashPerShare": 1.601, "ebitda": -231550000, "totalDebt": 57548000, "quickRatio": 8.262, "currentRatio": 8.477, "totalRevenue": 26748000, "debtToEquity": 17.659, "revenuePerShare": 0.079, "returnOnAssets": -0.24823, "returnOnEquity": -0.52494, "grossProfits": 14513000, "freeCashflow": -111265872, "operatingCashflow": -189996000, "revenueGrowth": 17.047, "grossMargins": 0.54258, "ebitdaMargins": 0.0, "operatingMargins": -4.30137, "financialCurrency": "USD", "symbol": "NUVB", "language": "en-US", "region": "US", "typeDisp": "Equity", "quoteSourceName": "Nasdaq Real Time Price", "triggerable": true, "customPriceAlertConfidence": "HIGH", "regularMarketChangePercent": 5.00556, "regularMarketPrice": 9.44, "messageBoardId": "finmb_639036735", "exchangeTimezoneName": "America/New_York", "exchangeTimezoneShortName": "EST", "gmtOffSetMilliseconds": -18000000, "market": "us_market", "esgPopulated": false, "shortName": "Nuvation Bio Inc.", "longName": "Nuvation Bio Inc.", "fiftyTwoWeekHighChangePercent": -0.009443878, "fiftyTwoWeekChangePercent": 253.55806, "earningsTimestamp": 1762203600, "earningsTimestampStart": 1762203600, "earningsTimestampEnd": 1762203600, "earningsCallTimestampStart": 1762205400, "earningsCallTimestampEnd": 1762205400, "isEarningsDateEstimate": false, "epsTrailingTwelveMonths": -0.49, "epsForward": -0.28, "epsCurrentYear": -0.45, "priceEpsCurrentYear": -20.977777, "fiftyDayAverageChange": 3.3267994, "fiftyDayAverageChangePercent": 0.54419935, "twoHundredDayAverageChange": 6.0944495, "twoHundredDayAverageChangePercent": 1.8216585, "sourceInterval": 15, "exchangeDataDelayedBy": 0, "averageAnalystRating": "1.2 - Strong Buy", "cryptoTradeable": false, "corporateActions": [], "postMarketTime": 1766192348, "regularMarketTime": 1766178003, "postMarketChangePercent": -0.3177938, "postMarketPrice": 9.41, "postMarketChange": -0.029999733, "regularMarketChange": 0.45, "regularMarketDayRange": "9.01 - 9.53", "fullExchangeName": "NYSE", "averageDailyVolume3Month": 8598193, "fiftyTwoWeekLowChange": 7.8999996, "fiftyTwoWeekLowChangePercent": 5.12987, "fiftyTwoWeekRange": "1.54 - 9.53", "fiftyTwoWeekHighChange": -0.09000015, "exchange": "NYQ", "marketState": "CLOSED", "hasPrePostMarketData": true, "firstTradeDateMilliseconds": 1598448600000, "displayName": "Nuvation Bio", "trailingPegRatio": null, "__fetch_time": "2025-12-20"}]